The AIRQ effectively identifies asthma exacerbation risk at 3 months and 12 months among patients with varying levels of asthma severity.

A new Senate report found that drug companies involved in price deals with Trump have continued to raise prices on hundreds of medications.

President Trump signed an executive order boosting federal research into psychedelic substances and expanding their use in controlled treatment settings.

Patients newly diagnosed with IPF at the time of a respiratory-related hospitalization had significantly shorter survival.